Sushma Munshi-Dhar

Sutton In Ashfield, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

Real-World Functional and Anatomical Outcomes of Intravitreal Faricimab in Suboptimal Responders With Neovascular Age-Related Macular Degeneration: A 24-Month Clinical Audit.

Real-World Functional and Anatomical Outcomes of Intravitreal Faricimab in Suboptimal Responders With Neovascular Age-Related Macular Degeneration: A 24-Month Clinical Audit.

Journal: Cureus

Published: June 19, 2026

Treatment of age-related macular degeneration with aflibercept using a treat, extend and fixed protocol; A 4-year study of treatment outcomes, durability, safety and quality of life (An extension to the MATE randomised controlled trial).

Treatment of age-related macular degeneration with aflibercept using a treat, extend and fixed protocol; A 4-year study of treatment outcomes, durability, safety and quality of life (An extension to the MATE randomised controlled trial).

Journal: Acta ophthalmologica

Published: February 19, 2023

The MATE trial: a multicentre, mixed-methodology, pilot, randomised controlled trial in neovascular age-related macular degeneration.

The MATE trial: a multicentre, mixed-methodology, pilot, randomised controlled trial in neovascular age-related macular degeneration.

Journal: Pilot and feasibility studies

Published: July 15, 2022

TANDEM TRIAL: a factorial randomised controlled trial of dose and review schedule of bevacizumab (Avastin) for neovascular macular degeneration in the East Midlands.

TANDEM TRIAL: a factorial randomised controlled trial of dose and review schedule of bevacizumab (Avastin) for neovascular macular degeneration in the East Midlands.

Journal: BMJ open ophthalmology

Published: August 06, 2020

Computer vision syndrome-A common cause of unexplained visual symptoms in the modern era.

Computer vision syndrome-A common cause of unexplained visual symptoms in the modern era.

Journal: International journal of clinical practice

Published: March 01, 2017

Prevalence of reticular pseudodrusen in newly presenting adult onset foveomacular vitelliform dystrophy.

Prevalence of reticular pseudodrusen in newly presenting adult onset foveomacular vitelliform dystrophy.

Journal: Eye (London, England)

Published: October 02, 2015

Prevalence of reticular pseudodrusen in eyes with newly presenting neovascular age-related macular degeneration.

Prevalence of reticular pseudodrusen in eyes with newly presenting neovascular age-related macular degeneration.

Journal: European journal of ophthalmology

Published: July 08, 2015

The diagnostic accuracy of spectral-domain optical coherence tomography for neovascular age-related macular degeneration: a comparison with fundus fluorescein angiography.

The diagnostic accuracy of spectral-domain optical coherence tomography for neovascular age-related macular degeneration: a comparison with fundus fluorescein angiography.

Journal: Eye (London, England)

Published: November 01, 2014

Comparing different dosing regimens of bevacizumab in the treatment of neovascular macular degeneration: study protocol for a randomised controlled trial.

Comparing different dosing regimens of bevacizumab in the treatment of neovascular macular degeneration: study protocol for a randomised controlled trial.

Journal: Trials

Published: September 08, 2014

Showing 1-9 of 9

Last Updated: 09/26/2026